Cibele S. Pinto

510 total citations
16 papers, 404 citations indexed

About

Cibele S. Pinto is a scholar working on Molecular Biology, Nephrology and Genetics. According to data from OpenAlex, Cibele S. Pinto has authored 16 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Nephrology and 5 papers in Genetics. Recurrent topics in Cibele S. Pinto's work include Renal Diseases and Glomerulopathies (7 papers), Biochemical and Molecular Research (5 papers) and Genetic and Kidney Cyst Diseases (4 papers). Cibele S. Pinto is often cited by papers focused on Renal Diseases and Glomerulopathies (7 papers), Biochemical and Molecular Research (5 papers) and Genetic and Kidney Cyst Diseases (4 papers). Cibele S. Pinto collaborates with scholars based in United States, Germany and France. Cibele S. Pinto's co-authors include Gail A. Reif, Darren P. Wallace, Roland Seifert, Tamio Yamaguchi, Hiroyuki Fujiki, Tung‐Chung Mou, Gerald H. Lushington, Archana Raman, Stephen R. Sprang and Andreas Gille and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and Journal of Neurochemistry.

In The Last Decade

Cibele S. Pinto

14 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cibele S. Pinto United States 10 273 200 73 67 38 16 404
Todd A. Fredrickson United States 11 360 1.3× 45 0.2× 24 0.3× 37 0.6× 7 0.2× 15 485
Erwen Huang China 13 247 0.9× 102 0.5× 15 0.2× 17 0.3× 8 0.2× 27 458
Lorne E. Seargeant Canada 11 377 1.4× 75 0.4× 36 0.5× 51 0.8× 3 0.1× 14 679
Eriko Kikuchi Japan 10 387 1.4× 28 0.1× 19 0.3× 56 0.8× 6 0.2× 20 476
Sharon Aviram Israel 9 228 0.8× 42 0.2× 19 0.3× 176 2.6× 9 0.2× 14 441
Charles McKay United States 7 235 0.9× 46 0.2× 43 0.6× 70 1.0× 14 0.4× 17 401
Emmanuel Coroneos United States 7 236 0.9× 26 0.1× 12 0.2× 14 0.2× 19 0.5× 8 390
Georg Lambert Switzerland 10 291 1.1× 66 0.3× 17 0.2× 187 2.8× 9 0.2× 14 426
Eun‐Hye Seo South Korea 12 241 0.9× 45 0.2× 18 0.2× 23 0.3× 4 0.1× 33 452
Naritoshi Shirata Japan 10 135 0.5× 25 0.1× 11 0.2× 43 0.6× 11 0.3× 11 332

Countries citing papers authored by Cibele S. Pinto

Since Specialization
Citations

This map shows the geographic impact of Cibele S. Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cibele S. Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cibele S. Pinto more than expected).

Fields of papers citing papers by Cibele S. Pinto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cibele S. Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cibele S. Pinto. The network helps show where Cibele S. Pinto may publish in the future.

Co-authorship network of co-authors of Cibele S. Pinto

This figure shows the co-authorship network connecting the top 25 collaborators of Cibele S. Pinto. A scholar is included among the top collaborators of Cibele S. Pinto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cibele S. Pinto. Cibele S. Pinto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ali, Sarah, Nicole Fusco, Vakaramoko Diaby, et al.. (2025). Burden of corticosteroid therapy in patients with immunoglobulin A nephropathy (IgAN): a systematic literature review. BMC Nephrology. 26(1). 249–249.
2.
Sim, John J., Qiaoling Chen, Ancilla W. Fernandes, et al.. (2025). CKD progression, kidney failure, and mortality among US patients with IgA nephropathy. Nephrology Dialysis Transplantation. 40(11). 2104–2117.
3.
Sim, John J., Qiaoling Chen, Simran K. Bhandari, et al.. (2024). Incidence of Adult Primary Immunoglobulin A Nephropathy among a Racially/Ethnically Diverse Population in the United States. American Journal of Nephrology. 56(2). 1–6. 2 indexed citations
4.
Mathur, Mohit, Tak Mao Chan, Kook‐Hwan Oh, et al.. (2023). A PRoliferation-Inducing Ligand (APRIL) in the Pathogenesis of Immunoglobulin A Nephropathy: A Review of the Evidence. Journal of Clinical Medicine. 12(21). 6927–6927. 8 indexed citations
5.
Pinto, Cibele S., Archana Raman, Gail A. Reif, et al.. (2015). Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology. 27(4). 1124–1134. 35 indexed citations
6.
Wallace, Darren P., Gail A. Reif, Cibele S. Pinto, et al.. (2013). Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease. Kidney International. 85(4). 845–854. 47 indexed citations
7.
Pinto, Cibele S., et al.. (2012). Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl−secretion by human autosomal dominant polycystic kidney cells. American Journal of Physiology-Renal Physiology. 303(10). F1412–F1424. 29 indexed citations
8.
Dixit, Anshuman, Tung‐Chung Mou, Gerald H. Lushington, et al.. (2011). Structural Basis for the High-Affinity Inhibition of Mammalian Membranous Adenylyl Cyclase by 2′,3′-O-(N-Methylanthraniloyl)-Inosine 5′-Triphosphate. Molecular Pharmacology. 80(1). 87–96. 11 indexed citations
9.
Pinto, Cibele S., Gerald H. Lushington, Mark L. Richter, et al.. (2011). Structure–activity relationships for the interactions of 2′- and 3′-(O)-(N-methyl)anthraniloyl-substituted purine and pyrimidine nucleotides with mammalian adenylyl cyclases. Biochemical Pharmacology. 82(4). 358–370. 18 indexed citations
10.
Reif, Gail A., et al.. (2011). Tolvaptan inhibits ERK-dependent cell proliferation, Cl−secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin. American Journal of Physiology-Renal Physiology. 301(5). F1005–F1013. 122 indexed citations
11.
Pinto, Cibele S., et al.. (2009). The C1 homodimer of adenylyl cyclase binds nucleotides with high affinity but possesses exceedingly low catalytic activity. Neuroscience Letters. 467(1). 1–5. 3 indexed citations
12.
Pinto, Cibele S., Andreas Gille, Mark L. Richter, et al.. (2009). Differential interactions of the catalytic subunits of adenylyl cyclase with forskolin analogs. Biochemical Pharmacology. 78(1). 62–69. 17 indexed citations
13.
Pinto, Cibele S., et al.. (2008). Activation and Inhibition of Adenylyl Cyclase Isoforms by Forskolin Analogs. Journal of Pharmacology and Experimental Therapeutics. 325(1). 27–36. 75 indexed citations
14.
Pinto, Cibele S., et al.. (2007). Complex changes in ecto-nucleoside 5′-triphosphate diphosphohydrolase expression in hypoxanthine phosphoribosyl transferase deficiency. Neuroscience Letters. 420(1). 6–11. 6 indexed citations
15.
Pinto, Cibele S. & Roland Seifert. (2005). Decreased GTP‐stimulated adenylyl cyclase activity in HPRT‐deficient human and mouse fibroblast and rat B103 neuroblastoma cell membranes. Journal of Neurochemistry. 96(2). 454–459. 16 indexed citations
16.
Pinto, Cibele S., Hyder A. Jinnah, Thomas L. Shirley, William L. Nyhan, & Roland Seifert. (2005). Altered membrane NTPase activity in Lesch–Nyhan disease fibroblasts: comparison with HPRT knockout mice and HPRT‐deficient cell lines. Journal of Neurochemistry. 93(6). 1579–1586. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Todd A. Fredrickson Breakdown of academic impact, for papers by Erwen Huang Breakdown of academic impact, for papers by Lorne E. Seargeant Breakdown of academic impact, for papers by Eriko Kikuchi Breakdown of academic impact, for papers by Sharon Aviram Breakdown of academic impact, for papers by Charles McKay Breakdown of academic impact, for papers by Emmanuel Coroneos Breakdown of academic impact, for papers by Georg Lambert Breakdown of academic impact, for papers by Eun‐Hye Seo Breakdown of academic impact, for papers by Naritoshi Shirata
Rankless by CCL
2026